Weixin Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Weixin Tang has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Wilfred A. van der Donk
University of Illinois at Urbana-Champaign
12 shared publications Hao Yan
Department of Chemistry, University of Chicago, Chicago, USA
6 shared publications- David R. Liu
Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
3 shared publications - Silvia C. Bobeica
Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at Urbana-Champaign, Urbana, USA
3 shared publications - Siyuan Zou
Department of Chemistry, The University of Chicago, Chicago, USA
3 shared publications - Yu-Lan Xiao
Department of Chemistry, The University of Chicago, Chicago, USA
3 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (6) , pgag187
A transfer RNA inosine modification drives genome-wide synonymous recoding across human commensal bacterial families
Inosine modification on transfer RNA (tRNA) anticodon (I34) is universally conserved in three kingdoms of life and critical to tRNA decoding capabilities. We found that tRNALeu(IAG) in commensal human bacterial families in Lactobaccilalles is concurrent with genome-wide synonymous leucine codon reprogramming. Pathway analysis reveals significant synonymous Leu codon changes in proteins in multiple KEGG pathways on cellular metabolism, where many genome-wide dominant UUA in families without tRNALeu(IAG) is reprogrammed to CUU, CUC, and UUG in families with tRNALeu(IAG). We provide biochemical and phenotypic results to support mechanisms that enable synonymous Leu codon substitutions to confer greater translation equivalency and growth fitness, indicating that a tRNA inosine modification can propel the genome-wide evolution of synonymous leucine codons.
- 30 May 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (6) , pgag187
Open AccessA transfer RNA inosine modification drives genome-wide synonymous recoding across human commensal bacterial families
Inosine modification on transfer RNA (tRNA) anticodon (I34) is universally conserved in three kingdoms of life and critical to tRNA decoding capabilities. We found that tRNALeu(IAG) in commensal human bacterial families in Lactobaccilalles is concurrent with genome-wide synonymous leucine codon reprogramming. Pathway analysis reveals significant synonymous Leu codon changes in proteins in multiple KEGG pathways on cellular metabolism, where many genome-wide dominant UUA in families without tRNALeu(IAG) is reprogrammed to CUU, CUC, and UUG in families with tRNALeu(IAG). We provide biochemical and phenotypic results to support mechanisms that enable synonymous Leu codon substitutions to confer greater translation equivalency and growth fitness, indicating that a tRNA inosine modification can propel the genome-wide evolution of synonymous leucine codons.
- 8 September 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (10) , 2498-2510
Multigenerational proteolytic inactivation of restriction upon subtle genomic hypomethylation in Pseudomonas aeruginosa
Restriction-modification (R-M) systems protect against phage infection by detecting and degrading invading foreign DNA. However, like many prokaryotic anti-phage defences, R-M systems pose a major risk of autoimmunity, exacerbated by the presence of hundreds to thousands of potential cleavage sites in the bacterial genome. Pseudomonas aeruginosa strains experience the temporary inactivation of restriction endonucleases following growth at high temperatures, but the reason and mechanisms for this phenomenon are unknown. Here we report that P. aeruginosa type I restriction endonuclease is degraded and the methyltransferase is partially degraded, by two Lon-like proteases when replicating at >41 °C. This post-translational regulation prevents self-DNA targeting, which is a risk due to stable genomic hypomethylation, as demonstrated by single-molecule, real-time sequencing and TadA-assisted N6-methyladenosine sequencing. When cells grown at >41 °C are returned to 37 °C, full genomic methylation does not fully recover for up to 60 bacterial generations, and thus restriction activity remains off for the duration. Our findings demonstrate that type I R-M is tightly regulated post-translationally with a long memory effect that ensures genomic stability and mitigates autotoxicity.
- 8 September 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (10) , 2498-2510
Multigenerational proteolytic inactivation of restriction upon subtle genomic hypomethylation in Pseudomonas aeruginosa
Restriction-modification (R-M) systems protect against phage infection by detecting and degrading invading foreign DNA. However, like many prokaryotic anti-phage defences, R-M systems pose a major risk of autoimmunity, exacerbated by the presence of hundreds to thousands of potential cleavage sites in the bacterial genome. Pseudomonas aeruginosa strains experience the temporary inactivation of restriction endonucleases following growth at high temperatures, but the reason and mechanisms for this phenomenon are unknown. Here we report that P. aeruginosa type I restriction endonuclease is degraded and the methyltransferase is partially degraded, by two Lon-like proteases when replicating at >41 °C. This post-translational regulation prevents self-DNA targeting, which is a risk due to stable genomic hypomethylation, as demonstrated by single-molecule, real-time sequencing and TadA-assisted N6-methyladenosine sequencing. When cells grown at >41 °C are returned to 37 °C, full genomic methylation does not fully recover for up to 60 bacterial generations, and thus restriction activity remains off for the duration. Our findings demonstrate that type I R-M is tightly regulated post-translationally with a long memory effect that ensures genomic stability and mitigates autotoxicity.
- 7 July 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (4) , 587-601
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
Base editors (BEs), covalent fusions of a cytosine or adenine deaminase with a nuclease-impaired CRISPR protein, mediate site-specific conversion of C:G to T:A (CBEs) or A:T to G:C (ABEs) in the genome. Existing BEs modify all cytosines or adenines within the editing window, which limits their precision. Here we engineer nucleotide and context specificity of the Escherichia coli transfer RNA-specific adenosine deaminase (TadA) to pinpoint cytosine editing. Strategically sampling multiple nucleic-acid-recognition hotspots through directed evolution, we develop 16 TadA-derived NCN-specific deaminases that cover every possible −1 and +1 context for a target cytosine, providing on-demand deaminase choices for editor customization. We apply these variants to (1) correct disease-associated T:A-to-C:G transitions documented by ClinVar, achieving greater accuracy than conventional CBEs in 81.5% of cases, and (2) model two cancer-driver mutations—KRASG12D (ACC) and TP53R248Q (CCG)—in vitro. Our approach offers a general strategy to access precise base editors for potential clinical applications.
- 7 July 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (4) , 587-601
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
Base editors (BEs), covalent fusions of a cytosine or adenine deaminase with a nuclease-impaired CRISPR protein, mediate site-specific conversion of C:G to T:A (CBEs) or A:T to G:C (ABEs) in the genome. Existing BEs modify all cytosines or adenines within the editing window, which limits their precision. Here we engineer nucleotide and context specificity of the Escherichia coli transfer RNA-specific adenosine deaminase (TadA) to pinpoint cytosine editing. Strategically sampling multiple nucleic-acid-recognition hotspots through directed evolution, we develop 16 TadA-derived NCN-specific deaminases that cover every possible −1 and +1 context for a target cytosine, providing on-demand deaminase choices for editor customization. We apply these variants to (1) correct disease-associated T:A-to-C:G transitions documented by ClinVar, achieving greater accuracy than conventional CBEs in 81.5% of cases, and (2) model two cancer-driver mutations—KRASG12D (ACC) and TP53R248Q (CCG)—in vitro. Our approach offers a general strategy to access precise base editors for potential clinical applications.
- 5 June 2025
- Published by Elsevier in Cell Chemical Biology
- Vol. 32 (6) , 789-808
Charting the development and engineering of CRISPR base editors: lessons and inspirations
- 5 June 2025
- Published by Elsevier in Cell Chemical Biology
- Vol. 32 (6) , 789-808
Charting the development and engineering of CRISPR base editors: lessons and inspirations
- Open Access
Advanced eTAM-seq enables high-fidelity, low-input N 6 -methyladenosine profiling in human cells and embryonic mouse tissues
Functional dissection of N6-methyladenosine (m 6 A), the most abundant internal messenger RNA modification in mammals, demands quantitative, scalable detection technology. We previously reported eTAM-seq, which supports transcriptome-wide quantification of m 6 A by enzyme-assisted adenosine deamination. While effective, TadA8.20—the enzyme used in our first-generation technology—is sensitive not only to m 6 A but also to RNA structure, making accurate detection dependent on the inclusion of control transcriptomes. Here, we introduce eTAM-seq-v2, in which we replace TadA8.20 with TadA8r, a further evolved adenosine deaminase with superior catalytic efficiency. eTAM-seq-v2 supports control-free m 6 A calling with high fidelity. Because enzyme treatment preserves RNA integrity, eTAM-seq surveys >51% of A sites in all expressed genes with moderate sequencing depth (60 million uniquely mapped reads) and delivers robust performance with as little as 10 ng of total RNA (∼500 cells). With eTAM-seq-v2, we delineate the m 6 A landscape across six human cell lines and seven embryonic mouse tissues. While uncovering broadly conserved m 6 A patterns, we reveal that most neighboring m 6 A sites are independently deposited at the single-molecule level. Moving forward, we envision that eTAM-seq-v2 will enable researchers to survey m 6 A in diverse biological contexts and uncover new insights into its regulatory roles.
Open AccessAdvanced eTAM-seq enables high-fidelity, low-input N 6 -methyladenosine profiling in human cells and embryonic mouse tissues
Functional dissection of N6-methyladenosine (m 6 A), the most abundant internal messenger RNA modification in mammals, demands quantitative, scalable detection technology. We previously reported eTAM-seq, which supports transcriptome-wide quantification of m 6 A by enzyme-assisted adenosine deamination. While effective, TadA8.20—the enzyme used in our first-generation technology—is sensitive not only to m 6 A but also to RNA structure, making accurate detection dependent on the inclusion of control transcriptomes. Here, we introduce eTAM-seq-v2, in which we replace TadA8.20 with TadA8r, a further evolved adenosine deaminase with superior catalytic efficiency. eTAM-seq-v2 supports control-free m 6 A calling with high fidelity. Because enzyme treatment preserves RNA integrity, eTAM-seq surveys >51% of A sites in all expressed genes with moderate sequencing depth (60 million uniquely mapped reads) and delivers robust performance with as little as 10 ng of total RNA (∼500 cells). With eTAM-seq-v2, we delineate the m 6 A landscape across six human cell lines and seven embryonic mouse tissues. While uncovering broadly conserved m 6 A patterns, we reveal that most neighboring m 6 A sites are independently deposited at the single-molecule level. Moving forward, we envision that eTAM-seq-v2 will enable researchers to survey m 6 A in diverse biological contexts and uncover new insights into its regulatory roles.
- Open Access
Deaminase-based RNA recording enables high throughput mutational profiling of protein-RNA interactions
Protein-RNA interactions regulate RNA metabolism and are frequently dysregulated in disease. Scalable methods are needed to connect RNA and protein sequence requirements across biochemical and cellular settings. Here, we use the engineered TadA8.20 deaminase to record protein-RNA recognition as nucleotide edits read by DNA sequencing. Using the λN-boxB complex, we establish a common recording readout for three complementary comparisons. Pooled mutational scanning on both the RNA and protein sides recovers key boxB nucleotides and λN residues involved in recognition. Comparison of boxB libraries in vitro and in human cells reveals conserved sequence requirements for protein-RNA recognition. Direct fusion and split recruitment of deaminase through nanobody and protein A/G fusions preserve similar patterns of sequence discrimination. Together, these results establish RNA recording as a scalable approach to map sequence determinants of protein-RNA recognition across molecular and cellular contexts.
Open AccessDeaminase-based RNA recording enables high throughput mutational profiling of protein-RNA interactions
Protein-RNA interactions regulate RNA metabolism and are frequently dysregulated in disease. Scalable methods are needed to connect RNA and protein sequence requirements across biochemical and cellular settings. Here, we use the engineered TadA8.20 deaminase to record protein-RNA recognition as nucleotide edits read by DNA sequencing. Using the λN-boxB complex, we establish a common recording readout for three complementary comparisons. Pooled mutational scanning on both the RNA and protein sides recovers key boxB nucleotides and λN residues involved in recognition. Comparison of boxB libraries in vitro and in human cells reveals conserved sequence requirements for protein-RNA recognition. Direct fusion and split recruitment of deaminase through nanobody and protein A/G fusions preserve similar patterns of sequence discrimination. Together, these results establish RNA recording as a scalable approach to map sequence determinants of protein-RNA recognition across molecular and cellular contexts.
- 8 July 2024
- Published by Springer Nature in Nature Chemical Biology
- Vol. 20 (12) , 1617-1628
Assessing and engineering the IscB–ωRNA system for programmed genome editing
OMEGA RNA (ωRNA)-guided endonuclease IscB, the evolutionary ancestor of Cas9, is an attractive system for in vivo genome editing because of its compact size and mechanistic resemblance to Cas9. However, wild-type IscB–ωRNA systems show limited activity in human cells. Here we report enhanced OgeuIscB, which, with eight amino acid substitutions, displayed a fourfold increase in in vitro DNA-binding affinity and a 30.4-fold improvement in insertion–deletion (indel) formation efficiency in human cells. Paired with structure-guided ωRNA engineering, the enhanced OgeuIscB–ωRNA systems efficiently edited the human genome across 26 target sites, attaining up to 87.3% indel and 62.2% base-editing frequencies. Both wild-type and engineered OgeuIscB–ωRNA showed moderate fidelity in editing the human genome, with off-target profiles revealing key determinants of target selection including an NARR target-adjacent motif (TAM) and the TAM-proximal 14 nucleotides in the R-loop. Collectively, our engineered OgeuIscB–ωRNA systems are programmable, potent and sufficiently specific for human genome editing.
- 8 July 2024
- Published by Springer Nature in Nature Chemical Biology
- Vol. 20 (12) , 1617-1628
Assessing and engineering the IscB–ωRNA system for programmed genome editing
OMEGA RNA (ωRNA)-guided endonuclease IscB, the evolutionary ancestor of Cas9, is an attractive system for in vivo genome editing because of its compact size and mechanistic resemblance to Cas9. However, wild-type IscB–ωRNA systems show limited activity in human cells. Here we report enhanced OgeuIscB, which, with eight amino acid substitutions, displayed a fourfold increase in in vitro DNA-binding affinity and a 30.4-fold improvement in insertion–deletion (indel) formation efficiency in human cells. Paired with structure-guided ωRNA engineering, the enhanced OgeuIscB–ωRNA systems efficiently edited the human genome across 26 target sites, attaining up to 87.3% indel and 62.2% base-editing frequencies. Both wild-type and engineered OgeuIscB–ωRNA showed moderate fidelity in editing the human genome, with off-target profiles revealing key determinants of target selection including an NARR target-adjacent motif (TAM) and the TAM-proximal 14 nucleotides in the R-loop. Collectively, our engineered OgeuIscB–ωRNA systems are programmable, potent and sufficiently specific for human genome editing.
- 5 July 2024
- Published by Springer Nature in Nature Chemical Biology
- Vol. 20 (10) , 1361-1370
Programmed RNA editing with an evolved bacterial adenosine deaminase
Programmed RNA editing presents an attractive therapeutic strategy for genetic disease. In this study, we developed bacterial deaminase-enabled recoding of RNA (DECOR), which employs an evolved Escherichia coli transfer RNA adenosine deaminase, TadA8e, to deposit adenosine-to-inosine editing to CRISPR-specified sites in the human transcriptome. DECOR functions in a variety of cell types, including human lung fibroblasts, and delivers on-target activity similar to ADAR-overexpressing RNA-editing platforms with 88% lower off-target effects. High-fidelity DECOR further reduces off-target effects to basal level. We demonstrate the clinical potential of DECOR by targeting Van der Woude syndrome-causing interferon regulatory factor 6 (IRF6) insufficiency. DECOR-mediated RNA editing removes a pathogenic upstream open reading frame (uORF) from the 5′ untranslated region of IRF6 and rescues primary ORF expression from 12.3% to 36.5%, relative to healthy transcripts. DECOR expands the current portfolio of effector proteins and opens new territory in programmed RNA editing.
- 5 July 2024
- Published by Springer Nature in Nature Chemical Biology
- Vol. 20 (10) , 1361-1370
Programmed RNA editing with an evolved bacterial adenosine deaminase
Programmed RNA editing presents an attractive therapeutic strategy for genetic disease. In this study, we developed bacterial deaminase-enabled recoding of RNA (DECOR), which employs an evolved Escherichia coli transfer RNA adenosine deaminase, TadA8e, to deposit adenosine-to-inosine editing to CRISPR-specified sites in the human transcriptome. DECOR functions in a variety of cell types, including human lung fibroblasts, and delivers on-target activity similar to ADAR-overexpressing RNA-editing platforms with 88% lower off-target effects. High-fidelity DECOR further reduces off-target effects to basal level. We demonstrate the clinical potential of DECOR by targeting Van der Woude syndrome-causing interferon regulatory factor 6 (IRF6) insufficiency. DECOR-mediated RNA editing removes a pathogenic upstream open reading frame (uORF) from the 5′ untranslated region of IRF6 and rescues primary ORF expression from 12.3% to 36.5%, relative to healthy transcripts. DECOR expands the current portfolio of effector proteins and opens new territory in programmed RNA editing.
- Open Access
- 15 April 2024
- Published by Wiley in Israel Journal of Chemistry
- Vol. 64 (3-4)
N6‐Methyladenosine in Mammalian Messenger RNA: Function, Location, and Quantitation
N6‐methyladenosine (m6A) is the most abundant internal modification in mammalian messenger RNA (mRNA), constituting 0.1 %–0.4 % of total adenosine residues in the transcriptome. m6A regulates mRNA stability and translation, pre‐mRNA splicing, miRNA biogenesis, lncRNA binding, and many other physiological and pathological processes. While the majority of m6As occur in a consensus motif of DRm6ACH (D=A/G/U, R=A/G, H=U/A/C), the presence of such a motif does not guarantee methylation. Different RNA copies transcribed from the same gene may be methylated to varying levels. Within a single transcript, m6As are not evenly distributed, showing an enrichment in long internal and terminal exons. These characteristics of m6A deposition call for sequencing methods that not only pinpoint m6A sites at base resolution, but also quantitate the abundance of methylation across different RNA copies. In this review, we summarize existing m6A profiling methods, with an emphasis on next generation sequencing‐(NGS−)based, site‐specific, and quantitative methods, as well as several emerging single‐cell methods.
- 15 April 2024
- Published by Wiley in Israel Journal of Chemistry
- Vol. 64 (3-4)
Open AccessN6‐Methyladenosine in Mammalian Messenger RNA: Function, Location, and Quantitation
N6‐methyladenosine (m6A) is the most abundant internal modification in mammalian messenger RNA (mRNA), constituting 0.1 %–0.4 % of total adenosine residues in the transcriptome. m6A regulates mRNA stability and translation, pre‐mRNA splicing, miRNA biogenesis, lncRNA binding, and many other physiological and pathological processes. While the majority of m6As occur in a consensus motif of DRm6ACH (D=A/G/U, R=A/G, H=U/A/C), the presence of such a motif does not guarantee methylation. Different RNA copies transcribed from the same gene may be methylated to varying levels. Within a single transcript, m6As are not evenly distributed, showing an enrichment in long internal and terminal exons. These characteristics of m6A deposition call for sequencing methods that not only pinpoint m6A sites at base resolution, but also quantitate the abundance of methylation across different RNA copies. In this review, we summarize existing m6A profiling methods, with an emphasis on next generation sequencing‐(NGS−)based, site‐specific, and quantitative methods, as well as several emerging single‐cell methods.
- Open Access
- 10 January 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (2) , 247-258
Profiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing
RNA-binding proteins (RBPs) regulate diverse cellular processes by dynamically interacting with RNA targets. However, effective methods to capture both stable and transient interactions between RBPs and their RNA targets are still lacking, especially when the interaction is dynamic or samples are limited. Here we present an assay of reverse transcription-based RBP binding site sequencing (ARTR-seq), which relies on in situ reverse transcription of RBP-bound RNAs guided by antibodies to identify RBP binding sites. ARTR-seq avoids ultraviolet crosslinking and immunoprecipitation, allowing for efficient and specific identification of RBP binding sites from as few as 20 cells or a tissue section. Taking advantage of rapid formaldehyde fixation, ARTR-seq enables capturing the dynamic RNA binding by RBPs over a short period of time, as demonstrated by the profiling of dynamic RNA binding of G3BP1 during stress granule assembly on a timescale as short as 10 minutes.
- 10 January 2024
- Published by Springer Nature in Nature Methods
- Vol. 21 (2) , 247-258
Open AccessProfiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing
RNA-binding proteins (RBPs) regulate diverse cellular processes by dynamically interacting with RNA targets. However, effective methods to capture both stable and transient interactions between RBPs and their RNA targets are still lacking, especially when the interaction is dynamic or samples are limited. Here we present an assay of reverse transcription-based RBP binding site sequencing (ARTR-seq), which relies on in situ reverse transcription of RBP-bound RNAs guided by antibodies to identify RBP binding sites. ARTR-seq avoids ultraviolet crosslinking and immunoprecipitation, allowing for efficient and specific identification of RBP binding sites from as few as 20 cells or a tissue section. Taking advantage of rapid formaldehyde fixation, ARTR-seq enables capturing the dynamic RNA binding by RBPs over a short period of time, as demonstrated by the profiling of dynamic RNA binding of G3BP1 during stress granule assembly on a timescale as short as 10 minutes.